Literature DB >> 22135084

Organotypic explant culture of glioblastoma multiforme and subsequent single-cell suspension.

Fumiko Shimizu1, Koos E Hovinga, Michael Metzner, Denis Soulet, Viviane Tabar.   

Abstract

Glioblastoma multiforme (GBM) is one of the most aggressive brain tumors. GBM cell lines used in laboratory studies are frequently passaged in various culture media at high proliferation rates, resulting in significant genetic and molecular alterations. Thus, data obtained in cell lines are often inapplicable to patient tumors. Furthermore, recent studies suggest that there is a stem cell-like hierarchy among GBM cell populations and a crucial role for tumor vasculature in stem cells, as well as tumor growth, which cannot be reproduced in cell line cultures. Our laboratory has developed a novel three-dimensional (3D) organotypic "explant" system of surgical GBM specimens that preserves tumor cells in their original milieu, as well as the cytoarchitecture of the tumor stroma. Our previous study on the role of Notch inhibition has demonstrated a definitive effect on the tumor endothelium that could only be highlighted by this system. In this unit, we describe a detailed protocol for preparing GBM explants, and discuss strengths, as well as limitations of the explant system as an in vitro 3D model of GBM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22135084     DOI: 10.1002/9780470151808.sc0305s19

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  7 in total

Review 1.  Brain stem cells as the cell of origin in glioma.

Authors:  Aram S Modrek; N Sumru Bayin; Dimitris G Placantonakis
Journal:  World J Stem Cells       Date:  2014-01-26       Impact factor: 5.326

2.  Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis.

Authors:  Xin Cui; Renee-Tyler Tan Morales; Weiyi Qian; Haoyu Wang; Jean-Pierre Gagner; Igor Dolgalev; Dimitris Placantonakis; David Zagzag; Luisa Cimmino; Matija Snuderl; Raymond H W Lam; Weiqiang Chen
Journal:  Biomaterials       Date:  2018-02-03       Impact factor: 12.479

3.  Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.

Authors:  Mark I James; Chinenye Iwuji; Glen Irving; Ankur Karmokar; Jennifer A Higgins; Nicola Griffin-Teal; Anne Thomas; Peter Greaves; Hong Cai; Samita R Patel; Bruno Morgan; Ashley Dennison; Matthew Metcalfe; Giuseppe Garcea; David M Lloyd; David P Berry; William P Steward; Lynne M Howells; Karen Brown
Journal:  Cancer Lett       Date:  2015-05-12       Impact factor: 8.679

4.  Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor.

Authors:  N Sumru Bayin; Lin Ma; Cheddhi Thomas; Rabaa Baitalmal; Akhila Sure; Kush Fansiwala; Mark Bustoros; John G Golfinos; Donato Pacione; Matija Snuderl; David Zagzag; Mary Helen Barcellos-Hoff; Dimitris Placantonakis
Journal:  Neoplasia       Date:  2016-12       Impact factor: 5.715

5.  Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy.

Authors:  Xin Cui; Chao Ma; Varshini Vasudevaraja; Jonathan Serrano; Jie Tong; Yansong Peng; Michael Delorenzo; Guomiao Shen; Joshua Frenster; Renee-Tyler Tan Morales; Weiyi Qian; Aristotelis Tsirigos; Andrew S Chi; Rajan Jain; Sylvia C Kurz; Erik P Sulman; Dimitris G Placantonakis; Matija Snuderl; Weiqiang Chen
Journal:  Elife       Date:  2020-09-10       Impact factor: 8.140

6.  An overview of therapeutic approaches to brain tumor stem cells.

Authors:  Alireza Khoshnevisan
Journal:  Med J Islam Repub Iran       Date:  2012-02

7.  Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system.

Authors:  Alexander Bolaender; Danuta Zatorska; Huazhong He; Suhasini Joshi; Sahil Sharma; Chander S Digwal; Hardik J Patel; Weilin Sun; Brandon S Imber; Stefan O Ochiana; Maulik R Patel; Liza Shrestha; Smit K Shah; Shuo Wang; Rashad Karimov; Hui Tao; Pallav D Patel; Ananda Rodilla Martin; Pengrong Yan; Palak Panchal; Justina Almodovar; Adriana Corben; Andreas Rimner; Stephen D Ginsberg; Serge Lyashchenko; Eva Burnazi; Anson Ku; Teja Kalidindi; Sang Gyu Lee; Milan Grkovski; Bradley J Beattie; Pat Zanzonico; Jason S Lewis; Steve Larson; Anna Rodina; Nagavarakishore Pillarsetty; Viviane Tabar; Mark P Dunphy; Tony Taldone; Fumiko Shimizu; Gabriela Chiosis
Journal:  Nat Commun       Date:  2021-08-03       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.